Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$185.1 - $233.13 $6,663 - $8,392
36 Added 3.56%
1,046 $241,000
Q3 2023

Oct 19, 2023

BUY
$233.08 - $265.59 $932 - $1,062
4 Added 0.4%
1,010 $250,000
Q2 2023

Jul 20, 2023

SELL
$224.99 - $256.14 $3,149 - $3,585
-14 Reduced 1.37%
1,006 $241,000
Q1 2023

May 10, 2023

SELL
$239.75 - $277.0 $4,315 - $4,986
-18 Reduced 1.73%
1,020 $257,000
Q4 2022

Feb 07, 2023

SELL
$241.42 - $282.29 $17,382 - $20,324
-72 Reduced 6.49%
1,038 $275,000
Q3 2022

Oct 24, 2022

BUY
$247.06 - $1507.4 $7,905 - $48,236
32 Added 2.97%
1,110 $287,000
Q2 2022

Jul 22, 2022

SELL
$237.11 - $299.66 $7,824 - $9,888
-33 Reduced 2.97%
1,078 $273,000
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $15,178 - $18,629
-59 Reduced 5.04%
1,111 $326,000
Q4 2021

May 10, 2022

BUY
$292.08 - $329.01 $341,733 - $384,941
1,170 New
1,170 $386,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Lockerman Financial Group, Inc. Portfolio

Follow Lockerman Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lockerman Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lockerman Financial Group, Inc. with notifications on news.